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Introduction
Lupus nephritis (LN) is a serious complication of juvenile-
onset systemic lupus erythematosus (JSLE). Current treat-
ments include long-term immunosuppressants with signif-
icant side effects. There is a need to identify targets for
more effective therapies. Toll-like receptors (TLRs)
perform an important role in the innate immune response
by recognising conserved molecules associated with patho-
gens. Previous studies have suggested a role for TLR7 and
TLR9 in lymphocytes in the pathogenesis of SLE.
Podocytes are specialised cells forming an important part
of the glomerular filtration barrier. Biopsies from LN
patients have demonstrated higher TLR7 and TLR9
expression in glomeruli compared with controls and
suggest that these TLRs are localised to podocytes. We
hypothesise that stimulation of TLR7 and/or TLR9 in
podocytes, acting via nuclear factor kappa B (NFkB), leads
to cellular damage and resultant kidney disease.
Objectives
This research aims to examine the role of TLR7 and
TLR9 in podocytes to identify potential targets for more
effective therapies of lupus nephritis.
Methods
Conditionally-immortalised human podocyte cell lines
were cultured to examine expression of TLRs and the
effects of their activation on the NFkB pathway and cell
proliferation. Reverse transcription-quantitative polymer-
ase chain reaction (RT-qPCR) and sodium dodecyl sul-
phate - polyacrylamide gel electrophoresis (SDS-PAGE)
with Western blotting were used to detect TLR7 and
TLR9 expression at the mRNA and protein level respec-
tively. The effects of lipopolysaccharide (LPS), an
inflammatory stimulus, on TLR expression were exam-
ined. Podocytes were stimulated with imiquimod, a
specific TLR7 agonist and CpG oligodeoxynucleotide
(ODN) 2216, a specific TLR9 agonist. Phosphorylation
of NFkB pathway components was assessed with Wes-
tern blotting and a cell proliferation assay used to
estimate cell survival following treatments. The effects
of treatment with TLR agonists in combination with
dexamethasone were also examined.
Results
Treatment of podocytes with LPS was associated with
increased expression of TLR7 at both mRNA and pro-
tein levels whereas there was comparatively little change
in TLR9. Exposure of the cells to imiquimod or CpG
ODN 2216 increased phosphorylation of NFkB. Initial
results from the cell proliferation assay suggested lower
levels after imiquimod or CpG ODN 2216 treatment for
24 hours. Since podocytes are terminally differentiated
this implies reduced cell numbers or lower metabolic
activity. Exposure of the podocytes to dexamethasone
was associated with lower expression of TLR7 and TLR9
at the mRNA level. There was preliminary evidence of
less phosphorylation of NFkB when cells were treated
with dexamethasone prior to TLR agonists compared
with the latter alone.
Conclusion
This study suggests that podocytes express TLR7 and
TLR9. Agonists of these receptors have effects on intra-
cellular signalling. If confirmed through ongoing work,
the TLR-NFkB pathway in kidney cells may be a poten-
tial target for novel therapies in lupus nephritis.
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